A better future for injectable contraception?

Provision of injectables though drug shops appears practicable and can contribute a marked share of family planning services. A potential longer-acting injectable providing at least 6 months of protection appeals to programmatic professionals. Subcutaneous administration of DMPA offers major injectable improvements over the current intramuscular approach. Ironically, while injectable use will inevitably grow, better choice and wider availability of other methods—especially of long-acting and permanent methods—will reduce injectables′ overall share.